Roctavian’s Benefits Sustained for Up to 5 Years in Trial Patients

Roctavian’s Benefits Sustained for Up to 5 Years in Trial Patients

Hemophilia News Today

Image

Please enable the javascript to submit this form

Supported by educational grants from Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc.

Essential SSL